Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

Clinical trial NCT06316076 · UNKNOWN

Trial details

NCT number: NCT06316076
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Idiopathic Inflammatory Myopathies Systemic Sclerosis

Start date: 2023-10-30
Primary completion: 2024-06-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.